(Q48611409)

English

Application of the findings of the European Stroke Prevention Study 2 (ESPS-2) to a New Zealand ischaemic stroke cost analysis

scientific article published in December 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/10175978

Application of the findings of the European Stroke Prevention Study 2 (ESPS-2) to a New Zealand ischaemic stroke cost analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/10175978

0 references

author name string

G Scott

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/10175978

H M Scott

2

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/10175978

publication date

1 December 1997

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/10175978

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/10175978

12

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/10175978

6

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/10175978

667-674

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/10175978

A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke

1 reference

https://pubmed.ncbi.nlm.nih.gov/10175978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ischaemic stroke and intracerebral haematoma in the Waikato Stroke Registry

1 reference

https://pubmed.ncbi.nlm.nih.gov/10175978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European Stroke Prevention Study 2: Baseline data

1 reference

https://pubmed.ncbi.nlm.nih.gov/10175978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10175978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1 reference

https://pubmed.ncbi.nlm.nih.gov/10175978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aspirin wars: the optimal dose of aspirin prevent stroke

1 reference

https://pubmed.ncbi.nlm.nih.gov/10175978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

1 reference

https://pubmed.ncbi.nlm.nih.gov/10175978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ischaemic stroke in New Zealand: an economic study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10175978

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-199712060-00006

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/10175978

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/10175978

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48611409&oldid=2209638526"